Latest News and Press Releases

Oslo, Norway, 22 May 2023 Vistin Pharma ASA (OSE: VISTIN): Please find attached the minutes from the Annual General Meeting held today, on the 22 May 2023. All matters were resolved as proposed...

In relation to the Annual General Meeting in Vistin Pharma ASA on the 22nd of May, the Company's Chair of the Board, Øyvin Brøymer, has received open proxies to represent a total of 3 905 611 shares...

Vistin Pharma will host a Capital Markets Day (CMD) for all interested parties on the 14th of June at its production plant in Stuttlidalen 4 at Fikkjebakke in Kragerø. The invitation is attached. ...

Oslo, Norway, 28 April 2023 Vistin Pharma ASA (OSE: VISTIN), please find attached the call for the Annual General Meeting in Vistin Pharma, to be held on 22 May at 13:00 CEST. A physical Annual...

Oslo, Norway, 27 April 2023 Please find attached the Annual Report for 2022 for Vistin Pharma ASA. There are no material changes in the financial statements compared to the preliminary full year...

Oslo, Norway, 27th of April 2023 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the first quarter of 2023. Revenue in the first quarter ended at MNOK 101...

Oslo, Norway, 20 April 2023 Vistin Pharma ASA will release its first quarter 2023 results on Thursday 27th of April 2023. Vistin Pharma will host a conference call for all shareholders and...

Oslo, Norway, 17th of February 2023 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the fourth quarter 2022 Det company enjoyed a very strong finishing...

Oslo, Norway, 10 February 2023 Vistin Pharma ASA will release its fourth quarter and preliminary 2022 results on Friday 17th of February 2023. Vistin Pharma will host a conference call for all...

Oslo, Norway, 9 December 2022 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) announces that it has entered into a long-term industrial energy agreement with Statkraft, the leading Norwegian energy...